Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges

Parkinson disease (PD) is a severe neurodegenerative disorder that affects around 2% of the population over 65 years old. It is characterized by the progressive loss of nigrostriatal dopaminergic neurons, resulting in motor disabilities of the patients. At present, only symptomatic cures are availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Agostini, Francesco, Masato, Anna, Bubacco, Luigi, Bisaglia, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745385/
https://www.ncbi.nlm.nih.gov/pubmed/35008822
http://dx.doi.org/10.3390/ijms23010398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745385/
https://www.ncbi.nlm.nih.gov/pubmed/35008822
http://dx.doi.org/10.3390/ijms23010398

Ejemplares similares